The masthead
About Dose Brief
The 5-minute GLP-1 briefing — prices, shortages, and provider moves.
Dose Brief is an independent newsroom, not a pharmacy or a telehealth company. We track what GLP-1 care actually costs week to week, whether the medications are in supply, and how the providers behind them change — then we distill it into a short brief you can read in five minutes.
Everything on the board is scored on our published Brief Score — the same six factors for every provider, whether or not we earn a commission from them. We say which is which on every card, and a commission never buys a higher score. Read the disclosure for exactly how the desk is funded.
The desk
Edited by The Dose Brief Desk, News Editor. A plain-English newsroom tracking GLP-1 prices, supply, and provider changes — and ranking the telehealth providers behind them on a published six-factor Brief Score.
Dose Brief is editorial information, not medical advice. Compounded GLP-1 medications are not FDA-approved finished drug products — talk to a licensed clinician before starting any weight-management medication. See our medical disclaimer.